Cardlytics (CDLX) Tops Q4 EPS by 28c, Beats on Revenue
Cardlytics (NASDAQ: CDLX) reported Q4 EPS of $0.00, $0.28 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $56.1 million versus the consensus estimate of $55.17 million.
For earnings history and earnings-related data on Cardlytics (CDLX) click here.
